[HTML][HTML] Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation
… been shown that chronic myelogenous leukemia cells produce … -inflammatory factors, myeloid
leukemia cells may reduce the … donor chimerism has been achieved (if recipient chimerism …
leukemia cells may reduce the … donor chimerism has been achieved (if recipient chimerism …
Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors
P Anur, DN Friedman, C Sklar, K Oeffinger… - … marrow transplantation, 2016 - nature.com
… donor chimerism, and 2 patients had >90% donor chimerism … disease-free survival comparing
the 13 patients who had pre-… stem cell transplantation for chronic myelogenous leukemia. …
the 13 patients who had pre-… stem cell transplantation for chronic myelogenous leukemia. …
[HTML][HTML] Monitoring TIGIT/DNAM-1 and PVR/PVRL2 immune checkpoint expression levels in allogeneic stem cell transplantation for acute myeloid leukemia
N Hattori, Y Kawaguchi, Y Sasaki, S Shimada… - … Marrow Transplantation, 2019 - Elsevier
… full donor chimerism (defined as ≥95% leukocytes of donor … of overall survival (OS),
progression-free survival (PFS), … Our findings suggest that TIGIT could be a prognostic predictor …
progression-free survival (PFS), … Our findings suggest that TIGIT could be a prognostic predictor …
Donor Lymphocyte Infusion (DLI) Post Allogeneic Stem Cell Transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome …
T Indran, T Das, J Muirhead, M O'Brien, M Swain… - Leukemia Research, 2024 - Elsevier
… responses observed in chronic myeloid leukemia (CML) … Data was collected from the bone
marrow transplant database… Reduced risk of relapse and improved disease-free survival …
marrow transplant database… Reduced risk of relapse and improved disease-free survival …
[HTML][HTML] … stem cell transplantation using high-dose post-transplantation cyclophosphamide is a suitable alternative for patients lacking HLA-matched donors
AS Jorge, M Suárez-Lledó, A Pereira… - … Marrow Transplantation, 2018 - Elsevier
… Progression-free survival and overall survival at 2 years were … Complete donor chimerism
was defined as the detection of >… Acute leukemia was the most frequent transplant indication (…
was defined as the detection of >… Acute leukemia was the most frequent transplant indication (…
[HTML][HTML] Status of natural killer cell recovery in day 21 bone marrow after allogeneic hematopoietic stem cell transplantation predicts clinical outcome
N Hattori, B Saito, Y Sasaki, S Shimada, S Murai… - … Marrow Transplantation, 2018 - Elsevier
… donor chimerism was defined as ≥95% leukocytes of donor … Progression-free survival (PFS)
was defined as the time from … in BM could be a powerful predictor of the clinical course and …
was defined as the time from … in BM could be a powerful predictor of the clinical course and …
Donor lymphocyte infusion in myeloid disorders
SK Toprak - Transfusion and Apheresis Science, 2018 - Elsevier
… The group of chronic myeloid leukemia patients who are … by French Society of Bone Marrow
Transplantation and Cell … cell chimerism might be effectively converted to full donor T cell …
Transplantation and Cell … cell chimerism might be effectively converted to full donor T cell …
Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in …
G Kharya, A Bakane, S Agarwal… - … Marrow Transplantation, 2021 - nature.com
… -free survival (DFS) of 88% with a median follow up of 485 … who had concurrent SCD and
acute myeloid leukemia [9]. This … All 22 alive patients had ≥95% donor chimerism in whole …
acute myeloid leukemia [9]. This … All 22 alive patients had ≥95% donor chimerism in whole …
[HTML][HTML] … stem cell transplant for patients with relapsed/refractory lymphoma: high incidence of long-term mixed donor-recipient chimerism and the response to donor …
C Burney, K Wadhera, P Breslin, R Pearce… - … Marrow Transplantation, 2020 - Elsevier
… The most common indication for receiving a DLI was MDRC (… myeloablative transplants,
mostly for acute myeloid leukemia … We report progression and extensive cGVHD-free survival of …
mostly for acute myeloid leukemia … We report progression and extensive cGVHD-free survival of …
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide
LK Schoch, KR Cooke, ND Wagner-Johnston… - Blood …, 2018 - ashpublications.org
… bone marrow transplantation with PTCy as GvHD prophylaxis. … The indication for alloBMT
was acute myeloid leukemia (AML)/… patients lost all evidence of donor chimerism by day 110. …
was acute myeloid leukemia (AML)/… patients lost all evidence of donor chimerism by day 110. …